The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Open accessAbstract
Fibroblasts are a dynamic cell type that achieve selective differentiated states to mediate acute wound healing and long-term tissue remodeling with scarring. With myocardial infarction injury, cardiomyocytes are replaced by secreted extracellular matrix proteins produced by proliferating and differentiating fibroblasts. Here, we employed 3 different mouse lineage-tracing models and stage-specific gene profiling to phenotypically analyze and classify resident cardiac fibroblast dynamics during myocardial infarction injury and stable scar formation. Fibroblasts were activated and highly proliferative, reaching a maximum rate within 2 to 4 days after infarction injury, at which point they expanded 3.5-fold and were maintained long term. By 3 to 7 days, these cells differentiated into myofibroblasts that secreted abundant extracellular matrix proteins and expressed smooth muscle α-actin to structurally support the necrotic area. By 7 to 10 days, myofibroblasts lost proliferative ability and smooth muscle α-actin expression as the collagen-containing extracellular matrix and scar fully matured. However, these same lineage-traced initial fibroblasts persisted within the scar, achieving a new molecular and stable differentiated state referred to as a matrifibrocyte, which was also observed in the scars of human hearts. These cells express common and unique extracellular matrix and tendon genes that are more specialized to support the mature scar.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and resemble POSTN-expressing matrifibrocytes7.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We used an Ang II/PE infusion model to study cardiac fibrosis which has inherent limitations3,4,7,39”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Computational lineage analysis predicted that FAP expression marks a fibroblast trajectory that transitions into populations including POSTN + matrifibrocytes 32 and myofibroblasts.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,108
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Joe, A. W. B., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., & Rossi, F. M. V. (2010) · Nature Cell Biology · doi:10.1038/ncb2015 · Cited by 1,690
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., & Kardon, G. (2011) · Development · doi:10.1242/dev.064162 · Cited by 1,249
Darby, I. A., Skalli, O., & Gabbiani, G. (1990) · PubMed · Cited by 1,189
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 5×
“We previously showed that myofibroblasts in the heart can dedifferentiate and revert back to an “uninjured” state after a cardiac stress response resolves, such as with Ang II/PE agonist infusion and then its removal (23).”
BackgroundInfluentialSelf-citationBryant, S. J., & Anseth, K. S. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1217 · Cited by 845
Research works printed but not linked: 1
- 10.1038/nature13839 · DOI · Paper page
Cited by
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Fibroblasts: Origins, definitions, and functions in health and disease
Plikus, M. V., Wang, X., Sinha, S., Forte, E., Thompson, S. M., Herzog, E. L., Driskell, R. R., Rosenthal, N., Biernaskie, J., & Horsley, V. (2021) · Cell · doi:10.1016/j.cell.2021.06.024 · Cited by 1,141
“, myofibroblasts) and proliferate transiently (Fu et al., 2018).”
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Hinz, B., & Lagares, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0324-5 · Cited by 614
Transcriptional and Cellular Diversity of the Human Heart
Tucker, N. R., Chaffin, M., Fleming, S. J., Hall, A. W., Parsons, V. A., Bedi, K. C., Akkad, A.-D., Herndon, C. N., Arduini, A., Papangeli, I., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045401 · Cited by 554
“[12,13] None of these clusters are enriched for expression of canonical markers for fibroblast activation (POSTN), myofibroblast transition (MYH11, FAP), or transformation to fibrocytes (CHAD, COMP) (Figure 3B).”
BackgroundFarbehi, N., Patrick, R., Dorison, A., Xaymardan, M., Janbandhu, V., Wystub-Lis, K., Ho, J. W., Nordon, R. E., & Harvey, R. P. (2019) · eLife · doi:10.7554/elife.43882 · Cited by 549
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.119.311148 · Cited by 520
Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure
Koenig, A. L., Shchukina, I., Amrute, J., Andhey, P. S., Zaitsev, K., Lai, L., Bajpai, G., Bredemeyer, A., Smith, G., Jones, C., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00028-6 · Cited by 482
“Fibroblasts are known to expand in heart failure and acquire an activated phenotype characterized by the expression of fibroblast activated protein (FAP) and periostin (POSTN) 33,45-50 .”
InfluentialMyofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation
Gibb, A. A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 434
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Mishra, S., & Kass, D. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00480-6 · Cited by 417
Fibroblasts in the Infarcted, Remodeling, and Failing Heart
Humeres, C., & Frangogiannis, N. G. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.02.006 · Cited by 410
“(137) Resident Tcf21þ cardiac fibroblasts become activated and proliferative within 2–4 days after nonreperfused infarction, then undergo myofibroblast conversion, secreting large amounts of ECM proteins.”
BackgroundTransforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
Tombor, L. S., John, D., Glaser, S. F., Luxán, G., Forte, E., Furtado, M., Rosenthal, N., Baumgarten, N., Schulz, M. H., Wittig, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20905-1 · Cited by 301
The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
Guo, Y., Yu, Y., Hu, S., Chen, Y., & Shen, Z. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2542-9 · Cited by 298
Targeting immune–fibroblast cell communication in heart failure
Amrute, J. M., Luo, X., Penna, V., Yang, S., Yamawaki, T., Hayat, S., Bredemeyer, A., Jung, I.-H., Kadyrov, F. F., Heo, G. S., et al. (2024) · Nature · doi:10.1038/s41586-024-08008-5 · Cited by 339
Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
Zeltz, C., Primac, I., Erusappan, P., Alam, J., Noel, A., & Gullberg, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.004 · Cited by 290
McLellan, M. A., Skelly, D. A., Dona, M. S. I., Squiers, G. T., Farrugia, G. E., Gaynor, T. L., Cohen, C. D., Pandey, R., Diep, H., Vinh, A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045115 · Cited by 287
“Indeed, Fibroblast-Cilp and Fibroblast-Thbs4 more closely resemble matrifibrocytes that reside in a mature scar after MI [15].”
BackgroundRole of PI3K/Akt signaling pathway in cardiac fibrosis
Qin, W., Cao, L., & Massey, I. Y. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04219-w · Cited by 277
Tallquist, M. D. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034527 · Cited by 272
“Two independent reports investigated the resident fibroblast response after myocardial infarction and observed that a strong proliferative burst resulted in 2–3 times more fibroblasts in the infarct region (53, 54).”
BackgroundHughes, T. K., Wadsworth, M. H., Gierahn, T. M., Do, T., Weiss, D., Andrade, P. R., Ma, F., de Andrade Silva, B. J., Shao, S., Tsoi, L. C., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.09.015 · Cited by 270
“35), a cartilage protein that is upregulated in matrix-producing fibroblasts after myocardial infarction (Fu et al., 2018).”
BackgroundRuiz-Villalba, A., Romero, J. P., Hernández, S. C., Vilas-Zornoza, A., Fortelny, N., Castro-Labrador, L., San Martin-Uriz, P., Lorenzo-Vivas, E., García-Olloqui, P., Palacio, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044557 · Cited by 260
Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction
Venugopal, H., Hanna, A., Humeres, C., & Frangogiannis, N. G. (2022) · Cells · doi:10.3390/cells11091386 · Cited by 248
“Lineage-tracing studies showed that in a mouse model of non-reperfused infarction, Tcf21 lineage cells were markedly reduced in the infarct zone as early as 2 days after coronary ischemia [38].”
BackgroundInfluentialA transcriptional switch governs fibroblast activation in heart disease
Alexanian, M., Przytycki, P. F., Micheletti, R., Padmanabhan, A., Ye, L., Travers, J. G., Gonzalez-Teran, B., Silva, A. C., Duan, Q., Ranade, S. S., et al. (2021) · Nature · doi:10.1038/s41586-021-03674-1 · Cited by 238
Xia, N., Lu, Y., Gu, M., Li, N., Liu, M., Jiao, J., Zhu, Z., Li, J., Li, D., Tang, T., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046789 · Cited by 227
Silva, A. C., Pereira, C., Fonseca, A. C. R. G., Pinto-do-Ó, P., & Nascimento, D. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.621644 · Cited by 221
Forte, E., Skelly, D. A., Chen, M., Daigle, S., Morelli, K. A., Hon, O., Philip, V. M., Costa, M. W., Rosenthal, N. A., & Furtado, M. B. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.008 · Cited by 216
Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities
Andreadou, I., Cabrera-Fuentes, H. A., Devaux, Y., Frangogiannis, N. G., Frantz, S., Guzik, T., Liehn, E. A., Gomes, C. P. C., Schulz, R., & Hausenloy, D. J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz050 · Cited by 213
Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level
Rao, M., Wang, X., Guo, G., Wang, L., Chen, S., Yin, P., Chen, K., Chen, L., Zhang, Z., Chen, X., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00897-1 · Cited by 212
Tuleta, I., & Frangogiannis, N. G. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166044 · Cited by 208
“In normal wound healing myofibroblasts eventually become quiescent, acquiring a unique profile of matrix protein expression that serves to preserve the scar in non-regenerative organs, such as the myocardium [7].”
BackgroundThe Role of the Epicardium During Heart Development and Repair
Quijada, P., Trembley, M. A., & Small, E. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315857 · Cited by 201
Hilgendorf, I., Frantz, S., & Frangogiannis, N. G. (2024) · Circulation Research · doi:10.1161/circresaha.124.323658 · Cited by 180
“436 The signals responsible for deactivation of infarct myofibroblasts remain enigmatic.”
Mechanical regulation of myofibroblast phenoconversion and collagen contraction
Hinz, B., McCulloch, C. A., & Coelho, N. M. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.027 · Cited by 182
Wang, Z., Cui, M., Shah, A. M., Tan, W., Liu, N., Bassel-Duby, R., & Olson, E. N. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108472 · Cited by 175
“These findings are consistent with documented myofibroblast gene profiles and mirror early steps of cardiac FB activation and differentiation to myofibroblasts (Forte et al., 2020; Fu et al., 2018).”
Cardiac Fibrosis and Fibroblasts
Kurose, H. (2021) · Cells · doi:10.3390/cells10071716 · Cited by 171
“Genetic lineage tracing was used to trace the fate of fibroblasts over time, after myocardial infarction [27].”
BackgroundMethodInfluentialTranscriptional heterogeneity of fibroblasts is a hallmark of the aging heart
Vidal, R., Wagner, J. U. G., Braeuning, C., Fischer, C., Patrick, R., Tombor, L., Muhly-Reinholz, M., John, D., Kliem, M., Conrad, T., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131092 · Cited by 167
“However, we could not find evidence for an increase of cells coexpressing mesenchymal and endothelial markers, which is compatible with recent lineage tracing studies, suggesting also that the extent to which endothelial cells contribute to heart fibroblasts after myocardial infarction is rather limited (24).”
ResultKang, S., Verma, S., Hassanabad, A. F., Teng, G., Belke, D. D., Dundas, J. A., Guzzardi, D. G., Svystonyuk, D. A., Pattar, S. S., Park, D. S. J., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.08.033 · Cited by 166
Mouton, A. J., Ma, Y., Rivera Gonzalez, O. J., Daseke, M. J., Flynn, E. R., Freeman, T. C., Garrett, M. R., DeLeon-Pennell, K. Y., & Lindsey, M. L. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0715-4 · Cited by 163
The bright side of fibroblasts: molecular signature and regenerative cues in major organs
Gomes, R. N., Manuel, F., & Nascimento, D. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00153-z · Cited by 194
Electroconductive biomaterials for cardiac tissue engineering
Esmaeili, H., Patino-Guerrero, A., Hasany, M., Ansari, M. O., Memić, A., Dolatshahi‐Pirouz, A., & Nikkhah, M. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.08.031 · Cited by 164
Liu, S., Li, K., Wagner, L., Tang, L., Heallen, T. R., Leach, J. P., Wang, Y., Grisanti, F., Willerson, J. T., Perin, E. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd6892 · Cited by 162
Guidelines for in vivo mouse models of myocardial infarction
Lindsey, M. L., Brunt, K. R., Kirk, J. A., Kleinbongard, P., Calvert, J. W., Brás, L. E. D. C., DeLeon‐Pennell, K. Y., Re, D. P. D., Frangogiannis, N. G., Frantz, S., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2021 · Cited by 156
Multipotent stromal cells: One name, multiple identities
Soliman, H., Theret, M., Scott, W., Hill, L., Underhill, T. M., Hinz, B., & Rossi, F. M. V. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.09.001 · Cited by 147
Tani, H., Sadahiro, T., Yamada, Y., Isomi, M., Yamakawa, H., Fujita, R., Abe, Y., Akiyama, T., Nakano, K., Kuze, Y., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058655 · Cited by 152
Xiao, Y., Hill, M. C., Li, L., Deshmukh, V., Martin, T. J., Wang, J., & Martin, J. F. (2019) · Genes & Development · doi:10.1101/gad.329763.119 · Cited by 149
“Cardiac myofibroblasts are highly proliferative and resistant to apoptosis; however, the cardiac myofibroblast cell state is transitory and lost by 10 d post-infarct (Fu et al. 2018).”
InfluentialThe interstitium in cardiac repair: role of the immune–stromal cell interplay
Forte, E., Furtado, M. B., & Rosenthal, N. A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0077-x · Cited by 159
Vascular cells improve functionality of human cardiac organoids
Voges, H. K., Foster, S. R., Reynolds, L., Parker, B. L., Devilée, L., Quaife-Ryan, G. A., Fortuna, P. R. J., Mathieson, E., Fitzsimmons, R., Lor, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112322 · Cited by 139
Maturation of heart valve cell populations during postnatal remodeling
Hulin, A., Hortells, L., Gomez‐Stallons, M. V., O’Donnell, A., Chetal, K., Adam, M., Lancellotti, P., Oury, C., Potter, S. S., Salomonis, N., et al. (2019) · Development · doi:10.1242/dev.173047 · Cited by 140
“Matrifibrocytes represent a specialized subpopulation of cardiac fibroblasts that remain within the mature scar of an injured heart (Fu et al., 2018).”
BackgroundStrontium ions protect hearts against myocardial ischemia/reperfusion injury
Xing, M., Jiang, Y. Y., Bi, W., Gao, L., Zhou, Y., Rao, S.-L., Ma, L., Zhang, Z.-W., Yang, H., & Chang, J. (2021) · Science Advances · doi:10.1126/sciadv.abe0726 · Cited by 128
“After infarction injury, fibroblasts and cardiomyocytes are partially killed within the ischemic area, and the remaining fibroblasts are activated to proliferate within 2 to 4 days to invade the necrotic area, followed by differentiation into myofibroblasts 3 to 7 days after injury to secrete abundant extracellular ma…”
BackgroundCardiac fibroblast activation during myocardial infarction wound healing
Daseke, M. J., Tenkorang, M. A. A., Chalise, U., Konfrst, S. R., & Lindsey, M. L. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.03.010 · Cited by 132
“[10] Collagen complexity over the infarct scar further increases from day 7 to day 21 producing a robust contractile scar.[15, 56]”
BackgroundMethodInfluentialHumeres, C. D., Shinde, A. V., Hanna, A., Alex, L., Hernández, S. C., Li, R., Chen, B., Conway, S. J., & Frangogiannis, N. G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146926 · Cited by 132
“During scar maturation, infarct fibroblasts and myofibroblasts transition to matrifibrocytes, specialized fibroblasts that synthesize genes typically expressed by chondroblasts and osteoblasts, such as Comp, Chad , and Clip2 (5).”
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-2
Wang, X., Banda, J., Qi, H., Chang, A. K., Bwalya, C., Chao, L., & Li, X. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.03.001 · Cited by 130
Key inflammatory mechanisms underlying heart failure
Riehle, C., & Bauersachs, J. K. (2019) · Herz · doi:10.1007/s00059-019-4785-8 · Cited by 138
Mori, Y., Novruzov, E., Schmitt, D. R., Cardinale, J., Watabe, T., Choyke, P. L., Alavi, A. A., Haberkorn, U., & Giesel, F. L. (2024) · npj Imaging · doi:10.1038/s44303-024-00053-z · Cited by 137
“Therefore, activated cardiac fi broblasts might serve as an attractive therapeutic target to modulate the remodeling process and improve functional outcomes 169,170 .”
Single-cell transcriptomics for the assessment of cardiac disease
Miranda, A. M. A., Janbandhu, V., Maatz, H., Kanemaru, K., Cranley, J., Teichmann, S. A., Hübner, N., Schneider, M. D., Harvey, R. P., & Noseda, M. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00805-7 · Cited by 117
Macrophages in myocardial infarction
Kubota, A., & Frangogiannis, N. G. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2022 · Cited by 130
Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner
Gladka, M. M., Kohela, A., Molenaar, B., Versteeg, D., Kooijman, L., Monshouwer‐Kloots, J., Kremer, V., Vos, H. R., Huibers, M. M. H., Haigh, J. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20361-3 · Cited by 112
Simonson, B., Chaffin, M. D., Hill, M. C., Atwa, O., Guedira, Y., Bhasin, H., Hall, A. W., Hayat, S., Baumgart, S. J., Bedi, K. C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112086 · Cited by 119
“4,5 These efforts have identified specific cell types, genes, and pathways that play crucial roles in ICM.”
Ale-Agha, N., Jakobs, P., Goy, C., Zurek, M., Rosen, J., Dyballa‐Rukes, N., Metzger, S. U., Greulich, J., von Ameln, F., Eckermann, O., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051923 · Cited by 110
Conserved NPPB + Border Zone Switches From MEF2- to AP-1–Driven Gene Program
van Duijvenboden, K., de Bakker, D. E. M., Man, J. C. K., Janssen, R., Günthel, M., Hill, M. C., Hooijkaas, I. B., van der Made, I., van der Kraak, P. H., Vink, A., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038944 · Cited by 109
Chemokines in Myocardial Infarction
Chen, B., & Frangogiannis, N. G. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10006-7 · Cited by 105
Mapping the cardiac vascular niche in heart failure
Peisker, F., Halder, M., Nagai, J. S., Ziegler, S. M., Kaesler, N., Hoeft, K., Li, R., Bindels, E. M., Kuppe, C., Moellmann, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30682-0 · Cited by 107
Intermediate filaments in cardiomyopathy
Tsikitis, M., Galata, Z., Mavroidis, M., Psarras, S., & Capetanaki, Y. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0443-2 · Cited by 120
Cardiac Fibroblast p38 MAPK: A Critical Regulator of Myocardial Remodeling
Turner, N. A., & Blythe, N. M. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6030027 · Cited by 103
Sierra: discovery of differential transcript usage from polyA-captured single-cell RNA-seq data
Patrick, R., Humphreys, D. T., Janbandhu, V. C., Oshlack, A., Ho, J. W. K., Harvey, R. P., & Lo, K. (2020) · Genome biology · doi:10.1186/s13059-020-02071-7 · Cited by 115
Mechanisms of cardiac collagen deposition in experimental models and human disease
Cowling, R. T., Kupsky, D. F., Kahn, A. M., Daniels, L. B., & Greenberg, B. (2019) · Translational research · doi:10.1016/j.trsl.2019.03.004 · Cited by 113
Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart
Khalil, H., Kanisicak, O., Vagnozzi, R. J., Johansen, A. K., Maliken, B. D., Prasad, V., Boyer, J. G., Brody, M. J., Schips, T. G., Kilian, K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128722 · Cited by 100
“Indeed, we have previously shown that fibroblasts normally undergo a 3-fold expansion with injury to the heart that is associated their ability to effectively generate fibrosis and a scar (47).”
BackgroundInfluentialSelf-citationPhysiological Biomimetic Culture System for Pig and Human Heart Slices
Ou, Q., Jacobson, Z., Abouleisa, R., Tang, X., Hindi, S. M., Kumar, A., Ivey, K. N., Giridharan, G. A., El-Baz, A. S., Brittian, K. R., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.314996 · Cited by 100
Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps
Xintarakou, A., Tzeis, S. E., Psarras, S., Asvestas, D., & Vardas, P. E. (2020) · EP Europace · doi:10.1093/europace/euaa009 · Cited by 105
Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy
Luczak, E. D., Wu, Y., Granger, J. M., Joiner, M.-L. A., Wilson, N. R., Gupta, A. K., Umapathi, P., Murphy, K. R., Gaido, O. E. R., Sabet, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18165-6 · Cited by 102
YAP/TAZ: Molecular pathway and disease therapy
Wei, Y., Hui, V. L. Z., Chen, Y., Han, R., Han, X., & Guo, Y. (2023) · MedComm · doi:10.1002/mco2.340 · Cited by 122
Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases
Liu, Y., Song, J.-W., Lin, J.-Y., Miao, R., & Zhong, J. (2020) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09603-4 · Cited by 92
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease
Shaw, T. J., & Rognoni, E. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00903-w · Cited by 94
Extracellular Matrix in Ischemic Heart Disease, Part 4/4
Frangogiannis, N. G., & Kovacic, J. C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.020 · Cited by 97
Inactivation of Sox9 in fibroblasts reduces cardiac fibrosis and inflammation
Scharf, G. M., Kilian, K., Cordero, J., Wang, Y., Grund, A., Hofmann, M., Froese, N., Wang, X., Kispert, A., Kist, R., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126721 · Cited by 89
“This might explain why we did not identify prominent differential regulation of cell cycle genes, because fibroblast proliferation occurs only between day 2 and day 7 after MI (25).”
BackgroundInfluentialAllanki, S., Strilić, B., Scheinberger, L., Onderwater, Y. L., Marks, A., Günther, S., Preussner, J., Kikhi, K., Looso, M., Stainier, D. Y. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg6497 · Cited by 84
Protein glycosylation in cardiovascular health and disease
Chatham, J. C., & Patel, R. P. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00998-z · Cited by 92
Brewer, C. M., Nelson, B. R., Wakenight, P., Collins, S., Okamura, D. M., Dong, X. R., Mahoney, W. M., McKenna, A., Shendure, J., Timms, A. E., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.09.008 · Cited by 86
Patrick, R., Janbandhu, V. C., Tallapragada, V. J., Tan, S. S. M., McKinna, E. E., Contreras, O., Ghazanfar, S., Humphreys, D. T., Murray, N. J., Tran, T. H. Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk8501 · Cited by 99
“These findings challenge our current view of MYO and MFCs ( 46 ).”
InfluentialFibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart
Umbarkar, P., Tousif, S., Singh, A. P., Anderson, J. C., Zhang, Q., Tallquist, M. D., Woodgett, J. R., & Lal, H. (2022) · Circulation Research · doi:10.1161/circresaha.122.321431 · Cited by 88
Zhu, L., Liu, Y., Wang, K., & Wang, N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102629 · Cited by 97
Fibroblast Memory in Development, Homeostasis and Disease
Kirk, T., Ahmed, A., & Rognoni, E. (2021) · Cells · doi:10.3390/cells10112840 · Cited by 84
“This new stable cell state, referred to as matrifibrocyte, expresses an ECM gene signature rich in bone-cartilage markers such as chondroadherin and cartilage oligomeric matrix protein (Comp), reminiscent of tendon, and is anticipated to promote a mature scar, respond differently to mechanical cues and support the hea…”
BackgroundPlatelet-derived growth factor receptor-α is essential for cardiac fibroblast survival
Ivey, M. J., Kuwabara, J. T., Riggsbee, K. L., & Tallquist, M. D. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00054.2019 · Cited by 80
Zhu, D., Liu, S., Huang, K., Li, J., Mei, X., Li, Z., & Cheng, K. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad114 · Cited by 81
Hypoxia-induced H19/YB-1 cascade modulates cardiac remodeling after infarction
Choong, O. K., Chen, C.-Y., Zhang, J., Lin, J.-H., Lin, P.-J., Ruan, S., Kamp, T. J., & Hsieh, P. C. H. (2019) · Theranostics · doi:10.7150/thno.35218 · Cited by 81
“abundantly expressed starting from day 3 to day 7 post-MI [38].”
BackgroundHuang, S., Chen, B., Su, Y., Alex, L., Humeres, C. D., Shinde, A. V., Conway, S. J., & Frangogiannis, N. G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.006 · Cited by 81
“Fibroblasts exhibit remarkable phenotypic plasticity, undergoing dramatic phenotypic changes in the dynamic environment of the infarct[3],[8],[9],[10].”
BackgroundShumliakivska, M., Luxán, G., Hemmerling, I., Scheller, M., Li, X., Müller-Tidow, C., Schuhmacher, B., Sun, Z., Dendorfer, A., Debes, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-43003-w · Cited by 76
Best, K. T., Nichols, A. E. C., Knapp, E. K., Hammert, W. C., Ketonis, C., Jonason, J. H., Awad, H. A., & Loiselle, A. E. (2020) · Science Signaling · doi:10.1126/scisignal.abb7209 · Cited by 81
Single-cell dual-omics reveals the transcriptomic and epigenomic diversity of cardiac non-myocytes
Wang, L., Yang, Y., Ma, H., Xie, Y., Xu, J., Near, D., Wang, H., Garbutt, T. A., Li, Y., Liu, J., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab134 · Cited by 74
Heterogeneity of the NIH3T3 Fibroblast Cell Line
Rahimi, A. M., Cai, M., & Hoyer‐Fender, S. (2022) · Cells · doi:10.3390/cells11172677 · Cited by 79
“Interestingly, in recent years, heart myofibroblasts have been reported to morph into a new differentiated state called ‘matrifibrocytes’ after wound healing, and it was proposed that the former approaches were based only on α-SMA detection and loss of α-SMA expression would have been interpreted as apoptosis of myofi…”
BackgroundVainio, L., Szabó, Z., Lin, R., Ulvila, J., Yrjölä, R., Alakoski, T., Piuhola, J., Koch, W. J., Ruskoaho, H. J., Fouse, S. D., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.10.007 · Cited by 83
“Recent studies indicated that the increase in LV fibrosis in the remote myocardium during post-MI LV remodeling was dependent on activation of existing FBs rather than FB proliferation, which mainly occurs 2 to 7 days post-MI in the infarct region (30).”
BackgroundThavapalachandran, S., Grieve, S. M., Hume, R. D., Le, T. Y. L., Raguram, K., Hudson, J. E., Pouliopoulos, J., Figtree, G. A., Dye, R. P., Barry, A. M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay2140 · Cited by 74
Single-cell transcriptomics following ischemic injury identifies a role for B2M in cardiac repair
Molenaar, B., Timmer, L. T., Droog, M., Perini, I., Versteeg, D., Kooijman, L., Monshouwer‐Kloots, J., de Ruiter, H., Gladka, M. M., & van Rooij, E. (2021) · Communications Biology · doi:10.1038/s42003-020-01636-3 · Cited by 80
Lai, Y., Tsai, F., Chang, G., Chang, S., Huang, C.-C., Chen, W.-J., & Yeh, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci142548 · Cited by 79
“1172/JCI142548 1 2 ence of miR-181b is required to elucidate the specific molecular mechanism of EndMT (51).”
BackgroundRegulators of cardiac fibroblast cell state
Bretherton, R. C., Bugg, D., Olszewski, E., & Davis, J. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.04.002 · Cited by 74
“that utilized Postn lineage tracing to track the genetic fate of activated cardiac fibroblasts [22].”
MethodDong, Y., Wang, B., Du, M., Zhu, B., Cui, K., Li, K. S., Yuan, K., Cowan, D. B., Bhattacharjee, S., Wong, S., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.063075 · Cited by 72
Dual genetic tracing reveals a unique fibroblast subpopulation modulating cardiac fibrosis
Han, M., Liu, Z., Liu, L., Huang, X., Wang, H., Pu, W., Wang, E., Liu, X., Li, Y., He, L., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01337-7 · Cited by 80
“3), which is consistent with previous studies showing reduced fibroblast marker expression after injury 28–31 .”
Cellular cross-talks in the diseased and aging heart
Wagner, J. U. G., & Dimmeler, S. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.152 · Cited by 84
Bugg, D., Bretherton, R. C., Kim, P., Olszewski, E., Nagle, A., Schumacher, A. E., Chu, N., Gunaje, J. J., DeForest, C. A., Stevens, K. R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316162 · Cited by 72
Xie, B., Wang, J., Xi, X., Guo, X., Chen, B.-X., Li, L., Hua, C., Zhao, S., Su, P., Chen, M., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05674-9 · Cited by 75
“According to MI-animal studies, cardiac fibroblast proliferation peaked from days 2 to 4 and declined through day 7, and the peak FAPI uptake was observed on day 6 after coronary ligation [11, 20].”
BackgroundResult
Metadata
- Authors
- Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., & Molkentin, J. D.
- Affiliations
- Louisiana State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2018-04-16
- Volume
- 128
- Issue
- 5
- Pages
- 2127-2143
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5957472
- OpenAlex
- W2800350399
- Cited by
- 636
- References
- 54
- Citations by year
- 2026: 58 · 2025: 81 · 2024: 71 · 2023: 93 · 2022: 87 · 2021: 86 · 2020: 90 · 2019: 52 · 2018: 17
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institutes of Health (R01 HL142217)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Keywords
- cardiac fibroblasts, myocardial infarction, scar formation, myofibroblasts, fibroblast differentiation, lineage tracing, extracellular matrix, smooth muscle actin, collagen, cardiac remodeling, wound healing
- MeSH terms
- Animals, Cell Differentiation, Cicatrix, Extracellular Matrix, Female, Humans, Male, Myocardial Infarction, Myocardium, Extracellular Matrix Proteins, Myoblasts, Cardiac, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.